Scholarly record
EU LEGISLATIVE SOLUTIONS REGARDING ENVIRONMENTAL RISK OF PHARMACEUTICAL PRODUCTS
Abstract
Considering the fact that the production of 1 kg of output in the pharmaceutical sector has a higher environmental impact than the production of 1 kg of output in the chemical industry, this article examines the way in which the specific legislation of the EU regarding medicinal products is adapted to the legislative instruments for the assessment and control of the environmental risks posed by medicinal products for human use during their life cycle, from production and up to the end of their life cycle. The European Union is the second largest consumer of medicinal products for human use (24% of the world total), after the United States of America, while the consumption phase is considered to be the greatest factor contributing to the release of medicinal products to the environment, especially by way of excretions and the improper disposal of unused medicines through sinks and toilets. As the pollution of waters and soils with pharmaceutical residues is an emerging environmental problem, the article aims to present the legal measures taken at EU level to monitor and assess the risks posed by medicinal products for human use to the environment, including those that may affect public health.
Publication Impact Profile
Publication details
References15
European Federation of Pharmaceutical Industries and Associations (EFPIA), The Pharmaceutical Industry in Figures, Key Data, 2016. Available at: http://www.efpia.eu/uploads/Modules/Documents/the-pharmaceutical-industry-in-figures-2016.pdf
Rodica Sirbu, Tania Zaharia, Simion Nicolaev, Alexandru Bologa, The Romanian Marine Ecosystem – an Important Source for the Pharmaceutical Industry: OCEANS-IEEE, Vols 1-5, 137-146, ISBN 978-0-933957-37-4, ISSN: 0197-7385, Conferince "Edge of Tomorrow" OCEANS 2007 MTS/IEEE, Vancouver, Canada, 2007.
Directive 2010/84/EU of the European Parliament and of the Council of 15 December 2010 amending, as regards pharmacovigilance, Directive 2001/83/EC on the Community code relating to medicinal products for human use, Official Journal of the European Union L 348 on 31.12.2010.
Tania Zaharia, Rodica Sîrbu, Simion Nicolaev, Dragos Micu, The Inventory of the Marine Habitats on the Romanian Littoral with Significance in Marine Conservation and Exploitation, Conference "Edge of Tomorrow" Oceans 2007 MTS/IEEE, Vancouver, Canada, 2007, (ISBN CD-ROM: 0-933957-35-1).
BIO Intelligence Service, Study on the environmental risks of medicinal products, Final Report prepared for Executive Agency for Health and Consumers, 12 December 2013. Available at: http://ec.europa.eu/health//sites/health/files/files/environment/study_environment.pdf
I. Stoicescu, Rodica Sîrbu, Ticuţa Negreanu-Pîrjol, M. Cociaşu, D. P. Balaban, C. Bala, In vitro antioxidant and antibacterial activity of Trapa Natans L. aquatic plant from Danube Delta area, Revue Roumaine de Chimie, Vol. 57, Issue: 7-8, 2012, pp. 729-733.
Sîrbu R., Negreanu-Pîrjol T., Paris S., Negreanu-Pîrjol B.S., Jurja S., A. Tomescu, „Important bioactive compounds from marine algae – potential source of pharmaceutical industry, 14th International Multidisciplinary Scientific GeoConferences „Surveying Geology & mining Ecology Management – SGEM 2014”, 17 – 26 June 2014, Conference Proceedings, Volume I, Section: Advances in Biotechnology, Albena, Bulgaria, 2014, pp. 381 – 388.
Sîrbu R., Zaharia, T., Negreanu-Pîrjol B.S., Nicolaev S., Bologa A., Psegalinschi I, The Black Sea ecosystem – important potential source for pharmaceutical industry, Journal of Environmental Protection and Ecology, vol. 11 (4), 2010, ISSN 1311-5065, pp. 1336-1348.
R. Sîrbu, T. Zaharia, V. Maximov, A.M. Bechir, M. Mariş, B. Negreanu-Pîrjol, D.Maris, T. Negreanu-Pîrjol, M. Leca, E. M. Cadar, R. M. Stoicescu, L. Mocanu, S. Jurja, Clean bio-technologies for obtaining new pharmaceutical formulations based on collagen gels and marine algae extracts for medical applications, Journal of Environmental Protection and Ecology, 11(2), 2010, ISSN1311-5064, pp. 654-665
EU Guidelines to Good Manufacturing Practice – Medicinal Products for Human and Veterinary Use, Doc. Ref. SANCO/C8/AM/sl/ares (2010) 1064597, last updated December 2010. See EudraLex - Volume 4 Good manufacturing practice (GMP) Guidelines, available at: ec.europa.eu/health/documents/eudralex/vol-4/index_en.htm.
R. Sîrbu, Aneta Tomescu, Sanda Jurja, Cristina-Luiza Erimia, Emin Cadar, Study of bioactiv pharmaceutical components from seaweeds from the Black Sea, 15th International Multidisciplinary Scientific GeoConference SGEM 2015, 16-25 June, 2015, Bulgaria, ISBN 978-619-7105-42-9, pp. 567-574.
Ana-Maria Neculai, Emin Cadar, Paris Stelian, Negreanu-Pîrjol Bogdan Ştefan, Rodica Sîrbu, Studies on natural compounds with glycozides with indole ring, 15th International Multidisciplinary Scientific GeoConference SGEM 2015, 16-25 June, 2015, Bulgaria, Vol. I, ISBN 978-619-7105-42-9,pp. 561-566.
EEA (2010), Pharmaceuticals in the environment. Technical report, No 1/2010. Available at: www.eea.europa.eu/publications/pharmaceuticals-in-the-environment-result-of-an-eea-workshop.
Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC, Official Journal of the European Union L 309 on 24.11.2009, Article 21.
Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products, Official Journal of the European Union L 167 on 27.6.2012, Annex VI (Common principles for the evaluation of dossiers for biocidal products), points 67 and 69.
View or Download full articleAccess options
SWS access login
Login as SWS Scientific CommitteeLogin as SWS Scientific PartnerLogin as SWS AuthorAuthors and approved SWS contributors will read and export their own linked papers after identity matching by SWS profile, email and SGEM GlobalID.
For librarian assistance: [email protected]
Purchase Instant Access
- Article can be downloaded after successful payment.
- Article may be used according to SWS library access terms.
- Article cannot be redistributed.
